secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2026-09-16T12:45:13+00:00
Accession:  0001493152-26-042844
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics, ReadyGo collaborate on blood-based PCR testing, starting with Ebola
--------------------------------------------------------------------------------

- Collaboration to test ReadyGo's GoCollect sample-prep with Co-Dx PCR platform for blood-based molecular testing at point of need.
- Initial focus on decentralized Ebola detection; WHO cites 6,757 confirmed cases, 3,267 deaths in DRC outbreak as of Sept 7, 2026.
- Feasibility work underway; no compatibility established yet; Co-Dx PCR platform not FDA cleared or available for sale.
- Success could expand platform to bloodborne pathogens including HIV and hepatitis B/C, representing larger markets than current swab menu.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226042844/0001493152-26-042844-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226042844/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042844

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer